Evidence map›Paper›PMID 38790236›Full record

ArticleGenes2024

Is

Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lana GanociDivision of Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0003-3898-4554
Jozefina PalićDepartment of Medical Chemistry, Biochemistry and Clinical Chemistry, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0002-3970-4721
Vladimir TrkuljaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0002-0968-1194
Katarina StarčevićDepartment of Neurology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0003-1561-4112
Livija ŠimičevićDivision of Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0002-2491-1920
Nada BožinaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Martina Lovrić-BenčićSchool of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Zdravka PoljakovićDepartment of Neurology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Tamara BožinaDepartment of Medical Chemistry, Biochemistry and Clinical Chemistry, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0001-5883-7979

Funding

Croatian Science Foundation UIP2020-02-8189
6 · The paper itself

Abstract

A recently discovered haplotype-

Indexed as

ClopidogrelCytochrome P-450 CYP2C19HaplotypesHemorrhagePlatelet Aggregation InhibitorsAgedFemaleGenotypeHumansMaleMiddle AgedTiclopidineClopidogrelCYP2C19 protein, humanCytochrome P-450 CYP2C19Platelet Aggregation InhibitorsTiclopidinebleedingclopidogrelCYP2C19 phenotypeCYP2C:TG haplotypeefficacy

Identifiers

PMID38790236
PMCPMC11121599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.